Renew Biopharma Inc CEO on Developing Biosynthetic Cannabinoid Therapeutics for TBI

2020-10-16T09:15:27-07:00April 25th, 2019|Latest Articles|

Renew Biopharma Inc is a research company developing proprietary therapeutics to treat neurodegenerative diseases, traumatic brain injuries (TBI), and for pain management. CEO Mike Mendez provides an introduction to the company and explains its interest in developing treatments using biosynthetic cannabinoids.